Ralliant Corporation $RAL is Irenic Capital Management LP’s 4th Largest Position

Irenic Capital Management LP increased its stake in shares of Ralliant Corporation (NYSE:RAL) by 424.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,740,218 shares of the company’s stock after purchasing an additional 1,408,176 shares during the quarter. Ralliant accounts for 4.8% of Irenic Capital Management LP’s holdings, making the stock its 4th largest holding. Irenic Capital Management LP’s holdings in Ralliant were worth $72,376,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the stock. Viking Global Investors LP purchased a new position in shares of Ralliant in the 2nd quarter valued at about $257,200,000. State Street Corp purchased a new stake in shares of Ralliant during the second quarter worth approximately $213,096,000. Millennium Management LLC raised its holdings in Ralliant by 172.4% in the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock valued at $253,175,000 after acquiring an additional 3,147,660 shares in the last quarter. Norges Bank purchased a new position in Ralliant in the fourth quarter worth approximately $124,687,000. Finally, Invesco Ltd. lifted its stake in Ralliant by 90.1% in the third quarter. Invesco Ltd. now owns 3,871,690 shares of the company’s stock worth $169,309,000 after acquiring an additional 1,835,128 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several research analysts have commented on RAL shares. Vertical Research cut shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target for the company. in a report on Wednesday, May 27th. TD Cowen lifted their price objective on shares of Ralliant from $55.00 to $70.00 and gave the stock a “buy” rating in a research report on Wednesday, May 20th. Weiss Ratings reiterated a “sell (d)” rating on shares of Ralliant in a research note on Monday, May 4th. Royal Bank Of Canada increased their target price on Ralliant from $64.00 to $71.00 and gave the company a “sector perform” rating in a report on Thursday, July 16th. Finally, Zacks Research upgraded Ralliant from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $73.00.

Ralliant Stock Performance

NYSE RAL opened at $67.69 on Wednesday. The company has a fifty day moving average of $66.83 and a two-hundred day moving average of $54.05. The company has a market capitalization of $7.58 billion and a PE ratio of -6.19. Ralliant Corporation has a 1 year low of $37.27 and a 1 year high of $75.41. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.61 and a quick ratio of 1.05.

Ralliant (NYSE:RAL) last posted its earnings results on Tuesday, May 12th. The company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.08. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The business had revenue of $534.60 million for the quarter. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. As a group, analysts expect that Ralliant Corporation will post 2.64 earnings per share for the current year.

Ralliant Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 8th were paid a $0.05 dividend. The ex-dividend date was Monday, June 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s payout ratio is currently -1.83%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.